Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The drugs control department of the Ministry of Health of the United Arab Emirates has issued a non-objection letter to the Imperial College London Diabetes Centre to import Generex Biotechnology Corporation's Oral-lyn, a proprietary oral insulin spray product, into Abu Dhabi.
Subscribe to our email newsletter
The manager of the drugs control department said that importation of Oral-lyn can be done via the issuance of a purchase order from the Imperial College London Diabetes Centre to a drug store or pharmacy licensed by the Ministry of Health of the United Arab Emirates.
Anna Gluskin, president and CEO of Generex, said: “We are pleased with the progress made by our Leosons General Trading Company. This step is significant in that it allows the company to introduce Generex Oral-lyn into the Middle East via an established organization with a strong diabetes treatment program. We anticipate that this model will serve the purpose of demonstrating the product’s safety and efficacy to other health agencies within the Middle East.”